US and Canadian anti-trust regulators conditionally approve Abbott-Alere merger

29 Sep 2017

Abbott Laboratories patches heart devices that could pose cybersecurity risks

31 Aug 2017

After price cap, Abbot seeks to withdraw stents from India

22 Apr 2017

Abbott, Alere agree to end legal battles, to go ahead with merger at lower price

15 Apr 2017

US regulators grant conditional approval to Abbott’s acquisition of St. Jude Medical

28 Dec 2016

US antitrust regulators yesterday approved Abbott Laboratories proposed $25-billion acquisition of medical device maker St. Jude Medical Inc on condition that it divests two medical device businesses

Abbott seeks to terminate $5.8-bn acquisition of Alere

08 Dec 2016

Abbott Laboratories has filed a plaint to terminate its proposed acquisition of Alere Inc due to a "substantial loss" in the value of Alere since the merger agreement was signed

European regulator conditionally approves Abbott's $25-bn deal for St Jude Medical

24 Nov 2016

Abbott offers EU concessions for antitrust approval of St Jude Medical acquisition

04 Nov 2016

Abbott Laboratories to sell eye care business to Johnson & Johnson for $4.325 bn

17 Sep 2016

Alere sues Abbott for completion of $5.8-bn merger

29 Aug 2016

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on Abbott Laboratories India from Informachine

Jan. 28, 2025

Jan. 28, 2025

30 Jan 2025

Abbott, the global healthcare company, announced the launch of Navitor Vision in India for the treatment of patients with symptomatic severe aortic stenosis who are at high or extreme surgical risk.

Nov. 27, 2024

Nov. 27, 2024

04 Dec 2024

Abbott, the global healthcare leader, announced today the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over 6 weeks of age.

Nov. 21, 2024

Nov. 21, 2024

21 Nov 2024

Abbott, the global healthcare company announced the launch of AVEIR™ VR single-chamber ventricular leadless pacemaker for the treatment of patients in India with slow heart rhythms.

Oct. 24, 2024

Oct. 24, 2024

30 Oct 2024

Abbott, the global healthcare leader, recently hosted the India chapter of the third edition of a:care Congress in collaboration with the Association of Physicians of India (API).

Sep. 25, 2024

Sep. 25, 2024

04 Oct 2024

Abbott announced the findings of a new survey among leading infectious disease experts around the world on the state of pandemic preparedness.

July 04, 2024

July 04, 2024

09 Jul 2024

Abbott, the global healthcare leader, launched its ‘Chakkar Ko Check Kar’ campaign in India to highlight an often-overlooked balance disorder, vertigo, which affects close to 70 million people in India.

July 01, 2024

July 01, 2024

09 Jul 2024

Abbott and YRGCARE Inaugurate New Innovative Outreach Centers in India, Offering Testing, Treatment and Support to Help Stop the Spread of HIV and Other Infectious Diseases

May 08, 2024

May 08, 2024

13 May 2024

Global healthcare leader Abbott announced the launch of its innovative automation solutions, GLP systems Track, to support laboratories’ high-volume needs.

May 02, 2024

May 02, 2024

07 May 2024

Abbott, the global healthcare company, announced the launch of XIENCE Sierra™ Everolimus (drug) Eluting Coronary Stent System in India.

View details about the software product Informachine News Trackers